Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000881409 | SCV001024581 | benign | not provided | 2023-12-20 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000881409 | SCV001716284 | uncertain significance | not provided | 2019-08-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000881409 | SCV003800066 | likely benign | not provided | 2023-09-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000881409 | SCV004138134 | benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | PIEZO1: BP4, BS1, BS2 |
Prevention |
RCV003910387 | SCV004725453 | benign | PIEZO1-related disorder | 2019-05-03 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |